General Updates | Treatment approach for multiple myeloma with CNS relapse
Ezzat El Hassadi
• 20 Oct 2022
Ezzat El Hassadi, MD, University Hospital Waterford, Waterford, Ireland, discusses advances in treatment strategies for multiple myeloma with central nervous system (CNS) relapse. Dr El Hassadi explains how a combination of daratumumab with triple intrathecal chemotherapy has shown high efficacy towards treating this rare form of relapse. Dr El Hassadi further comments on the efficacy of brain and spine radiotherapy for multiple myeloma with CNS relapse. This interview was recorded virtually.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
